Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 15, 2023

Total Value: $82.49M (100.0% shares, 0.0% debt)

Holdings (27)

ALDX Aldeyra Therapeutics Inc 30.7%
Value $25.3M Shares 3,015,668 Est. Cost $7.17 Unrealized +37.5%
Biohaven Pharmactl Hldg Co L 13.1%
Value $10.77M Shares 450,422 Est. Cost $32.04 Unrealized
Avadel Pharmaceuticals Plc 10.0%
Value $8.24M Shares 500,000 Est. Cost $16.48 Unrealized
HOOKIPA PHARMA 5.9%
Value $4.855M Shares 5,517,385 Est. Cost $0.87 Unrealized
Applied Therapeutics Inc 5.4%
Value $4.416M Shares 3,450,000 Est. Cost $5.66 Unrealized
Verona Pharma 5.1%
Value $4.228M Shares 200,000 Est. Cost $22.97 Unrealized
GDX Vaneck Gold Miners ETF 3.4%
Value $2.766M Shares 91,850 Est. Cost $28.66 Unrealized
SIL Global X Silver Miners ETF 37954Y848 2.8%
Value $2.331M Shares 89,700 Est. Cost $28.17 Unrealized
ENTX Entera Bio Ltd 2.5%
Value $2.094M Shares 2,484,275 Est. Cost $3.46 Unrealized -75.3%
GDXJ Vaneck Junior Gold Miners ETF 2.3%
Value $1.895M Shares 53,150 Est. Cost $35.65 Unrealized
BAH Booz Allen Hamilton HLDG COR 1.8%
Value $1.451M Shares 13,000 Est. Cost $76.36 Unrealized +22.6%
V Visa 1.4%
Value $1.152M Shares 4,850 Est. Cost $203.18 Unrealized +10.5%
TMO Thermo Fischer Scientific Inc 1.3%
Value $1.096M Shares 2,100 Est. Cost $471.13 Unrealized +13.6%
OCUL Ocular Therapeutix Inc. 1.3%
Value $1.032M Shares 200,000 Est. Cost $4.75 Unrealized +25.2%
MO Altria Group Inc 1.2%
Value $1.028M Shares 22,700 Est. Cost $30.41 Unrealized +20.2%
CVS CVS Health Corp 1.2%
Value $1.002M Shares 14,500 Est. Cost $62.28 Unrealized +3.2%
FNV Franco Nev Corp CAD 1.2%
Value $998K Shares 7,000 Est. Cost $135.73 Unrealized +7.9%
Silvercrest Metals Inc CAD 1.2%
Value $996K Shares 170,000 Est. Cost $6.14 Unrealized
NOC Northrop Grumman Corp 1.2%
Value $987K Shares 2,165 Est. Cost $442.02 Unrealized -1.9%
OSISKO GOLD ROYALTIES LTD 1.2%
Value $969K Shares 400,000 Est. Cost $2.88 Unrealized
Omega Therapeutics Inc. 1.2%
Value $969K Shares 173,010 Est. Cost $6.03 Unrealized
SA SEABRIDGE GOLD INC 1.2%
Value $964K Shares 80,000 Est. Cost $14.95 Unrealized -9.1%
Orgenesis, Inc. 1.1%
Value $882K Shares 634,738 Est. Cost $6.08 Unrealized
OCUL Ocular Therapeutix Inc. 1.0%
Value $814K Shares 95,800 Est. Cost $4.75 Unrealized +25.2%
ALT Altimmune Inc 0.7%
Value $614K Shares 173,864 Est. Cost $12.66 Unrealized -64.5%
IRD Ocuphire Pharma Inc. 0.5%
Value $434K Shares 100,000 Est. Cost $3.59 Unrealized +32.2%
BioXcell 0.2%
Value $200K Shares 30,000 Est. Cost $6.66 Unrealized